Abstract: The present application discloses a method of treating cancer, including administering to a person suffering from cancer or in remission from cancer, an antigen presenting cell loaded with an immunogenic CD4 T cell activating antigen and a CD8 T cell activating neoantigen specific for the cancer.
Type:
Application
Filed:
September 15, 2022
Publication date:
April 27, 2023
Applicant:
Celloram Inc.
Inventors:
Seunghwan Lim, Tej Kumar Pareek, Liraz Levi, Seong-Jin Kim